CHANDRANNI QUINONES: Open Payments
NPI 1588753800 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,603 in 62 payments from 16 companies in 2025. Trend: 2023 $1,383 · 2024 $1,170 · 2025 $1,603
Food & beverage: $1,504Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $301 |
| ABBVIE INC. | 9 | $270 |
| UCB, Inc. | 6 | $230 |
| Incyte Corporation | 12 | $225 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 7 | $132 |
| LEO Pharma Inc. | 3 | $77 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $58 |
| GENZYME CORPORATION | 2 | $57 |
| Amgen Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
Products named: TREMFYA, Bimzelx, OPZELURA, SKYRIZI, Cabtreo, RINVOQ, ILUMYA, DUPIXENT.
Industry payments across CT — which companies pay providers there.
